Literature DB >> 17982115

Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc.

Jennifer A Benanti1, Myra L Wang, Hadley E Myers, Kristin L Robinson, Carla Grandori, Denise A Galloway.   

Abstract

The transcription factor c-Myc is implicated in the pathogenesis of many cancers. Among the multiple functions of c-Myc, activation of hTert and other genes involved in cellular life span contributes to its role as an oncogene. However, the ability of c-Myc to directly immortalize human cells remains controversial. We show here that overexpression of c-Myc reproducibly immortalizes freshly isolated human foreskin fibroblasts. c-Myc-immortalized cells displayed no gross karyotypic abnormalities but consisted of an oligoclonal population, suggesting that additional events cooperated to achieve immortalization. Levels of p53 and p16 were increased, but both p53-dependent DNA damage response and growth arrest in response to p16 overexpression remained intact. A marked decrease in expression of the tumor suppressor ARF occurred in several independently established c-Myc-immortalized cell lines. Methylation-specific PCR showed that the ARF gene was methylated in immortalized but not early-passage c-Myc cells, whereas p16 was unmethylated in both cell populations. Restoration of ARF expression by treatment with a demethylating agent or overexpression by a retroviral vector coincided with inhibition of proliferation and senescence of c-Myc-immortalized cells. Our findings predict that epigenetic events play a significant role in human tumors that express high levels of c-Myc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982115     DOI: 10.1158/1541-7786.MCR-06-0372

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  21 in total

1.  Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.

Authors:  Xuefeng Liu; Aleksandra Dakic; Renxiang Chen; Gary L Disbrow; Yiyu Zhang; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

2.  Gene expression signature of c-MYC-immortalized human fibroblasts reveals loss of growth inhibitory response to TGFβ.

Authors:  Myra L Wang; Ryan Walsh; Kristin L Robinson; Julja Burchard; Steven R Bartz; Michele Cleary; Denise A Galloway; Carla Grandori
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

3.  Functional genomics identifies therapeutic targets for MYC-driven cancer.

Authors:  Masafumi Toyoshima; Heather L Howie; Maki Imakura; Ryan M Walsh; James E Annis; Aaron N Chang; Jason Frazier; B Nelson Chau; Andrey Loboda; Peter S Linsley; Michele A Cleary; Julie R Park; Carla Grandori
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-23       Impact factor: 11.205

Review 4.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

5.  Hypoxia-derived oxidative stress mediates epigenetic repression of PKCε gene in foetal rat hearts.

Authors:  Andrew J Patterson; Daliao Xiao; Fuxia Xiong; Brandon Dixon; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2011-12-02       Impact factor: 10.787

6.  The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.

Authors:  Antje Menssen; Per Hydbring; Karsten Kapelle; Jörg Vervoorts; Joachim Diebold; Bernhard Lüscher; Lars-Gunnar Larsson; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-21       Impact factor: 11.205

7.  Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma.

Authors:  Sarasija Naini; Katherine T Etheridge; Stacey J Adam; Stephen J Qualman; Rex C Bentley; Christopher M Counter; Corinne M Linardic
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

8.  Inactivation of the p19(ARF) tumor suppressor affects intestinal epithelial cell proliferation and integrity.

Authors:  Tiffany E Farmer; Christopher S Williams; M Kay Washington; Scott W Hiebert
Journal:  J Cell Biochem       Date:  2008-08-15       Impact factor: 4.429

Review 9.  Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

Authors:  Silvia Cermelli; In Sock Jang; Brady Bernard; Carla Grandori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

10.  Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus.

Authors:  Ryan Webb; Jonathan D Wren; Matlock Jeffries; Jennifer A Kelly; Kenneth M Kaufman; Yuhong Tang; Mark Barton Frank; Joan Merrill; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Graciela S Alarcón; Luis M Vilá; Marta E Alarcón-Riquelme; Judith A James; Timothy J Vyse; Kathy L Moser; Patrick M Gaffney; Gary S Gilkeson; John B Harley; Amr H Sawalha
Journal:  Arthritis Rheum       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.